Literature DB >> 34337001

RNA-seq-Based Screening in Coal Dust-Treated Cells Identified PHLDB2 as a Novel Lung Cancer-Related Molecular Marker.

Deyong Ge1,2,3, Yuhan Shao3, Mengjie Wang3, Huihui Tao1,2,3, Min Mu1,2,3, Xinrong Tao1,2,3.   

Abstract

Lung cancer is one of the most serious leading cancers with high incidence globally. Identifying molecular markers is key for disease diagnosis and treatment. Coal dust might be important triggering factors in disease development. Here, we first performed RNA-seq-based screening in coal dust treated and nontreated RAW264.7 cell lines. PHLDB2 was found to be the top differentially expressed gene. By retrieving TCGA lung cancer dataset, we observed that PHLDB2 showed upregulations in males and smoker patients. Patients with lower PHLDB2 expression survived longer than those with higher expressions. Furthermore, PHLDB2 was negatively correlated with EMT makers, and a total of 2.74% mutation rate were observed in 1,059 patients. This finding highlights the critical role of PHLDB2 in lung cancer development. PHLDB2 might be a molecular maker for disease diagnosis or treatment.
Copyright © 2021 Deyong Ge et al.

Entities:  

Year:  2021        PMID: 34337001      PMCID: PMC8314042          DOI: 10.1155/2021/1978434

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


1. Introduction

Lung cancer is one of the most serious leading cancers with high incidence globally. In China, lung cancer ranked the first male and second female cancer incidence according to the recent cancer epidemiology report [1]. During the past twenty years, the crude incidence of lung cancer had been increased dramatically, which caused Chinese cancer bunder the heaviest one around the world. To better control the lung cancer bunder, the government and enterprises made great effort to minimize air pollution, tobacco abuse, emissions of automotive exhausts, and some other restrictions. Lung cancer is a kind of complex malignant disease with both genetic and strong environment background. Up to date, with the advantage of genome-wide association study and high-throughput next generation sequencing technology, tens of susceptibility loci or gene mutations have been identified in Chinese lung cancer cohorts. Particularly, some disease-driven genes, such as PIK3CA, KRAS, and EGFR, involved in the receptor tyrosine kinase (RTK) pathway, facilitated us to better understand the etiology of disease [2-4]. Even though these genes provide clues in disease development, the accurate molecular mechanism remains largely unknown. As been widely confirmed, environmental pollution is a high-risk factor for lung cancer. The workers exposed with dust, coal mining, pottery manufacturing, and other kinds of particles, usually containing crystalline silica component, might face the risk of lung cancer [5-7]. The more concentration and longer duration of exposure increased the risk of cancer. Furthermore, when mice delivered with silica particles by inhalation, they developed typical tumor phenotype, suggesting that silica particles might cause lung cancer in rodent animals [8]. The real molecular mechanisms underlying this process are still elusive, but more and more evidence suggest that macrophages and neutrophils are the key cell types that mediate the disease development. The chronic inflammation or fibrosis might occur because of the phagocytic dysfunction [9]. It is largely believed that silica might trigger chronic pulmonary inflammation by inducing chemokine or cytokine like IL-1, IL-6, and TNF, and eventually caused hyperproliferation of epithelial cells [10]. In current study, to better understand how coal dust influence gene expression profile of cultured macrophage cell line, we induce RAW264.7 cells with coal dust then performed RNA-seq, and we identified PHLDB2 as the top gene that significantly upregulated the coal dust treatment group. To verify our observations, we compared the expression level in the lung cancer and normal control group using the TCGA dataset. Further investigations suggested that those with elevated expression PHLDB2 might survive shorter than those with lower expression. These findings revealed that PHLDB2 might contribute to lung cancer by phagocyte dust through macrophage cells.

2. Materials and Methods

2.1. Cell Culture and Cytotoxicity Test

RAW264.7 cells were cultured in DMEM high sugar medium (Hyclone, USA) with 10% fetal bovine serum (ExCell Bio, China) and 1% penicillin/streptomycin, in humidified incubator at 37°C with 5% CO2. The coal dust was collected from a coal mine located in Shanxi Province, China. After grinding, the average diameter of dust particle was lower than 5 μm. Then, coal dust was autoclaved and sonicated and dissolved in DMEM medium with the final concentration 20 mg/mL for long time storage. We cultured RAW264.7 with 0.125 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 1 mg/mL, 2 mg/mL, and measured the cell viability. The CCK8 assay kit (Biosharp, China) was used to evaluate cell viability.

2.2. The Process of RNA-seq Data

The total RNA of all 12 cultured cells was extracted with QiagenRNA easy mini kit (Cat No.: 74106, Germany). After controlling the quality and quantity of RNA with nanodrop and electrophoresis, the qualified RNA samples were converted into cDNA, then fragmentation, adaptor ligation, and amplification and were finally loaded into Illumina next generation sequencer. Skewer was used to remove adaptor sequence and trim those with low quality. Samples with both QC 20% > 95% and QC 30% > 90%, calculated with FastQC, were entered into next step. STAR software was used to align the clean data to the human genome reference, with parameters: --twopassModeBasic|--outSAMstrandFieldintronMotif|--alignSJstitchMismatchNmax 5-1 5 5. Transcripts were assembled, and read counts were generated with StringTie software. Differential gene expressions were detected with edgeR package (http://bioconductor.org/packages/release/bioc/html/edgeR.html).

2.3. Public Data Mining

We downloaded the RNA-seq data of 1,014 non-small-cell lung cancer subjects from Genomic Data Commons (GDC,https://portal.gdc.cancer.gov/). Gene expression data of 578 controls were downloaded from GTEx V8 release version (https://gtexportal.org/home/datasets). For the Kaplan-Meier survival analysis, log ranked survival time was compared between each group. Mean time represents the mean survival time of 50% overall survival probability.

2.4. Statistical Analysis

The differential expression was performed with R package. Student's t-test was used to generate the p value in treated and nontreated cell lines. The Wilcoxon rank sum test was used to compare the gene expression difference among cancer and normal groups. Kaplan-Meiersurvival analysis was fixed with “Survival” and “Survminer.” Significance threshold was set at p < 0.05.

3. Results

3.1. Cytotoxicity of Dust-Treated RAW264.7 Cells

To check whether coal dust affects the viability of RAW264.7 cells, we treated cells with different concentrations of dust-containing medium. CCK-8 assays revealed that low concentration dust showed limited effect on cell viability, while cells were significantly inhibited by coal dust with concentration more than 0.5 mg/mL. At concentration 2.0 mg/mL, the average cell viability decreased 44% when compared with control cells, suggesting coal dust might affect RAW264 in high concentration (Figure 1).
Figure 1

Cell viability was tested in normal RAW264.7 cells and treated with different concentrations of dust-containing medium. All tests were replicated by more than five times. Two tail Student t-test p value was evaluated the statistical significance (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001).

3.2. RNA-seq Findings of Dust-Treated and Nontreated Cells

To reveal whether coal dust impact gene expression profile in RAW264.7 cell lines, we performed RNA-seq in six dust-treated and six nontreated cells. We selected coal dust concentration at 1 mg/mL for the transcriptome sequencing, because the cell viability showed strong alteration at this point [11, 12]. We deemed that this concertation was high enough to induce the expression of key mediators that modulated cell viability. The mean clean reads were 47.0 M per sample, with an average mapping rate of 90.1%. PCA analysis showed that the dust-treated group clearly separates from the nontreated group, suggesting reliability of our sequencing data (Figure 2(a)). Using R package edgeR, we calculate expression difference between two groups. With adjusted p < 0.05, we found 24 differentially expressed genes (Supplementary Table 1). The most significant gene is PHLDB2 which upregulated about 28.6 folds. We noticed 91.6% (22/24) gene showed upregulated expression while only two represent decreased expression. For upregulated genes, the second top three were ATP13A5, MC5R, and PRKG1, while GDA and PCDHA2 decreased dramatically.
Figure 2

RNA-seq profile of coal dust-treated and nontreated cells. (a) Principle component analysis (PCA) revealed clear separation from treated (RA-S) and nontreated (RA-C) groups. (b) KEGG pathway analysis of 24 differentially expressed genes.

These genes might modulate the macrophage function in some signaling pathways. We thus carried out a pathway analysis for all differentially expressed genes. Four pathways showed changes with “Neuroactive ligand-receptor interaction” ranked the first one with raw p value 1.2 × 10−3; however, none passed significance threshold after correction (Figure 2(b)). These findings suggested that coal dust might induce expression changes in macrophage cell lines with the most differentially expressed genes, PHLDB2.

3.3. PHLDB2 Might Be Involved in Lung Cancer

PHLDB2 was the top differentially expressed gene, while it has not been reported with coal dust-exposed lung-related disease. Interestingly, PHLDB2 was implicated in other kinds of cancer, such asrenal cell carcinoma and gastric and colorectal cancer [13-15]. We then asked whether PHLDB2 was related with lung cancer. By retrieving TCGA lung cancer expression data and checked expression status in patients, normal controls, smokers, and nonsmokers, the TCGA dataset included 1,014 patients and 578 controls. PHLDB2 showed significantly lower expression in cancer patients when compared with controls (p = 4.5 × 10−73, Figure 3(a)). When patients were classified into different clinical stages, we observed an increasing trend that T3 tumors presented with slightly upregulation (Figure 3(d)). Male patients obtained elevated expression than those in female groups (p = 1.2 × 10−8, Figure 3(b)). Furthermore, PHLDB2 was significantly higher in smoker cancer patients than in nonsmokers (p = 1.0 × 10−4, Figure 3(c)).
Figure 3

The PHLDB2 expression in different groups. (a) The PHLDB2 expression was decreased in cancer patients compared with normal controls. Upregulated PHLDB2 levels were observed in male (b) and smoker patients (c). (d) The PHLDB2 expression in different clinical stages. Wilcox ranked test p value was used to mark the statistical significance.

Interestingly, the expression of PHLDB2 was decreased in lung cancer tissues, but showed a mosaic change in various kinds of cancer types in a pan-cancer analysis with TCGA data (with upregulation in HNSC (head and neck squamous cell carcinoma), PAAD (pancreatic adenocarcinoma), DLBC (lymphoid neoplasm diffuse large B-cell lymphoma), and some others, while showed downregulation in LUAD (lung adenocarcinoma) and LUSC (lung squamous cell carcinoma) (Supplementary Figure 1). These findings implied that PHLDB2 might contribute to different cancers with different functions. The PHLDB2 expression was associated with survival rate, suggesting higher expression carriers survived shorter than those with lower expression (Figure 4(a)).T3 stage patients expressed slightly higher PHLDB2 level, and they survived shorter than T1 and T2 stage patients. The median survival time is 5.9 ys, 4.1 ys, and 2.6 ys for T1, T2, and T3 stages, respectively (Figure 4(b)).
Figure 4

Survival analysis of patients with higher or lower PHLDB2 expression level (a) and in different clinical stages (b).

We noticed that PHLDB2 was negatively correlated with some EMT markers, suggesting that PHLDB2 might contribute to lung cancer by regulating the EMT process (Figure 5(a)). For the previous key findings in current study, we then asked whether PHLDB2 mutations contributed to lung cancer. In the TCGA mutation database, we found 29 mutations in the coding and flanking regions of PHLDB2, representing 2.74% of 1,059 cancer patients. When looked in detail, the 29 mutations consisted of 25 missense, 3 nonsense, and 1 splicing mutation (Figure 5(b)). Almost all mutations appeared in the patients with relatively lower PHLDB2 expression. These findings from the public dataset implied that PHLDB2 might be involved in lung cancer development.
Figure 5

PHLDB2 expression was negatively correlated with EMT markers (a). PHLDB2 mutation landscape in lung cancer patients from the TCGA dataset (b).

4. Discussion

In current study, we first executed RNA-seq for coal dust-treated and nontreated macrophage cell line RAW264.7. We found 24 genes that showed differential gene expression between two groups, with PHLDB2 served as the most significant gene. The 24 genes also showed enrichment trend that was involved in “Neuroactive ligand-receptor interaction” signaling pathway. By retrieving the TCGA public dataset, we observed that PHLDB2 was significantly decreased in lung cancer patients, while those with higher expression survived longer, suggesting PHLDB2 might play protective role in caner development. There were 2.74% patients that carried PHLDB2 mutations. In summary, RNA-seq-based strategies helped us identified PHLDB2 as a new lung cancer-related maker. Coal dust is a mixture of copper, lead, zinc, and some other particulate matters 2.5 μm (PM 2.5). Long-term exposure to coal dust might induce severe lung disease, such as pneumoconiosis, pulmonary fibrosis, and even lung cancer. It is commonly believed that lung fibrosis might be mediated by macrophages, neutrophils, and Th17 cells [16], even though the exact molecular mechanism is still under debate. Our study provides some evidence that PHLDB2 might modulate disease initiation or progression through macrophage, based on RNA-seq-based screening strategy. PHLDB2, also known as pleckstrin homology-like domain family B member 2, has been implicated in the several other types of cancers [17, 18]. The main function of PHLDB2 is regulating migration by interacting with CLASPS, prickle 1, and liprin α1 [19, 20]. This macromolecular complex plays a critical role in assembling focal adhesion and is essential for cell polarization and migration. Indeed, PHLDB2 has diverse roles in regulating cell migration or EMT (epithelial–mesenchymal transition). We found that PHLDB2 was negatively correlated with several EMT markers, suggesting that PHLDB2 might be involved in the EMT process. However, this point cannot be figured out in current study because of our limited data. A recent report revealed that NOTCH3 might promote cell proliferation, monolayer formation, or cell invasion of gastric carcinogenesis through PHLDB2. Furthermore, PHLDB2 signals can be transduced into Akt signaling pathway, because PHLDB2 knockdown inhibited the activation of Akt and mTOR [14]. Meanwhile, pan-cancer analysis suggested PHLDB2 upregulated or down regulated in different types of cancer, implying that PHLDB2 might contribute to different cancers with different functions. There were also some other possibilities that the PHLDB2 expression alteration was just the consequence of some signaling pathways, like the miR-875-5p-NOTCH3- pathway, which might be regulated by several undetermined factors. Even PHLDB2 might be holding the same function in EMT, while the network of controlling EMT is really far beyond the scope of our current study and also the other types of cancer. Particularly, recent bioinformatic strategies revealed interesting findings that some immune-related genes are linked to lung adenocarcinoma. Whether PHLDB2 is connected to these genes or signaling pathways needs further investigation. The limitation of this study mainly stands in two points. First, PHLDB2 was found in the RAW264.7 macrophage cell line. How PHLDB2 contributes to lung cancer? Does it the signal that macrophage communicates with epithelial cell? Even the typical phenotype of coal dust inhalation was lung fibrosis, what is the functions of PHLDB2 in fibrosis? Second, most of our findings were based on statistical analysis of public dataset, and further investigation was fundamental to confirm these results. In summary, using RNA-seq-based screening strategy, we detected that PHLDB2 might be a potential lung cancer-related marker. These findings will help us to better understand the etiology of coal dust-induced lung disease.
  20 in total

1.  The efficacy of local exhaust ventilation for controlling dust exposures during concrete surface grinding.

Authors:  Gerry A Croteau; Mary Ellen Flanagan; Janice E Camp; Noah S Seixas
Journal:  Ann Occup Hyg       Date:  2004-08-06

2.  p53 and K-ras mutations in lung tissues and sputum samples of individuals exposed to smoky coal emissions in Xuan Wei County, China.

Authors:  Phouthone Keohavong; Qing Lan; Weimin Gao
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2018-03-30       Impact factor: 2.873

3.  A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.

Authors:  Zhibin Hu; Chen Wu; Yongyong Shi; Huan Guo; Xueying Zhao; Zhihua Yin; Lei Yang; Juncheng Dai; Lingmin Hu; Wen Tan; Zhiqiang Li; Qifei Deng; Jiucun Wang; Wei Wu; Guangfu Jin; Yue Jiang; Dianke Yu; Guoquan Zhou; Hongyan Chen; Peng Guan; Yijiang Chen; Yongqian Shu; Lin Xu; Xiangyang Liu; Li Liu; Ping Xu; Baohui Han; Chunxue Bai; Yuxia Zhao; Haibo Zhang; Ying Yan; Hongxia Ma; Jiaping Chen; Mingjie Chu; Feng Lu; Zhengdong Zhang; Feng Chen; Xinru Wang; Li Jin; Jiachun Lu; Baosen Zhou; Daru Lu; Tangchun Wu; Dongxin Lin; Hongbing Shen
Journal:  Nat Genet       Date:  2011-07-03       Impact factor: 38.330

4.  The effects of Thorotrast and quartz on the induction of lung tumors in rats.

Authors:  A Spiethoff; H Wesch; K Wegener; H J Klimisch
Journal:  Health Phys       Date:  1992-07       Impact factor: 1.316

5.  Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation.

Authors:  Takashi Sato; Takeshi Shimosato; W Gregory Alvord; Dennis M Klinman
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

6.  Prickle1 promotes focal adhesion disassembly in cooperation with the CLASP-LL5β complex in migrating cells.

Authors:  Boon Cheng Lim; Shinji Matsumoto; Hideki Yamamoto; Hiroki Mizuno; Junichi Kikuta; Masaru Ishii; Akira Kikuchi
Journal:  J Cell Sci       Date:  2016-07-04       Impact factor: 5.285

7.  Oncoprotein mdig contributes to silica-induced pulmonary fibrosis by altering balance between Th17 and Treg T cells.

Authors:  Chitra Thakur; Michael Wolfarth; Jiaying Sun; Yadong Zhang; Yongju Lu; Lori Battelli; Dale W Porter; Fei Chen
Journal:  Oncotarget       Date:  2015-02-28

8.  NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway.

Authors:  Wei Kang; Jinglin Zhang; Tingting Huang; Yuhang Zhou; Chi Chun Wong; Ronald C K Chan; Yujuan Dong; Feng Wu; Bin Zhang; William K K Wu; Michael W Y Chan; Alfred S L Cheng; Jun Yu; Nathalie Wong; Kwok Wai Lo; Ka Fai To
Journal:  Oncogene       Date:  2021-01-15       Impact factor: 9.867

9.  Lung cancer in patients diagnosed with silicosis should be investigated.

Authors:  Adil Can Güngen; Yusuf Aydemir; Hikmet Çoban; Hasan Düzenli; Canantan Tasdemir
Journal:  Respir Med Case Rep       Date:  2016-04-27

10.  TNFR/TNF-α signaling pathway regulates apoptosis of alveolar macrophages in coal workers' pneumoconiosis.

Authors:  Qing-Zeng Qian; Xiang-Ke Cao; Hai-Yan Liu; Guo-Ying Zheng; Qing-Qiang Qian; Fu-Hai Shen
Journal:  Oncotarget       Date:  2017-07-01
View more
  1 in total

1.  Prognostic Modeling of Lung Adenocarcinoma Based on Hypoxia and Ferroptosis-Related Genes.

Authors:  Chang Liu; Yan-Qin Ruan; Lai-Hao Qu; Zhen-Hua Li; Chao Xie; Ya-Qiang Pan; Hao-Fei Li; Ding-Biao Li
Journal:  J Oncol       Date:  2022-09-19       Impact factor: 4.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.